Skip to main content
Signal8
Prasad Deepa profile photo

Deepa Prasad

CIK: 0001867165

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Design Therapeutics, Inc. logo
DSGN

Design Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Jun 10, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    19K shares-
  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Dec 18, 2024
    Sale(S)
    Direct
    3.8K shares at avg. $6.27$24K

1-2 of 2

About Prasad Deepa

Prasad Deepa (SEC CIK 0001867165) files insider reports with the SEC as Director of Design Therapeutics, Inc. (DSGN).

Signal8 holds 2 ownership filings by Prasad Deepa, all Form 4s, filed between Dec 19, 2024 and Jun 12, 2025. Those filings report 2 transactions, from Dec 18, 2024 to Jun 10, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Prasad Deepa's filings is in CARLSBAD, CA.

Recent filings by Prasad Deepa

  • Jun 10, 2025: Grant or award of DSGN derivative securities (Form 4, code A).
  • Dec 18, 2024: Open-market sale of DSGN shares (Form 4, code S).

Other insiders filing for Design Therapeutics, Inc. (DSGN)

How to read Form 4 transaction codes